Hongyu Zhuo

Five‐year analysis from phase 2 trial of “sandwich” chemoradiotherapy in newly diagnosed, stage <scp>IE</scp> to <scp>IIE</scp> , nasal type, extranodal natural killer/T‐cell lymphoma

Li Zhang, Ming Jiang, Li Xie et al. · Cancer Medicine · 2015 · 46 citations · Full text

Medicine, Oncology, Radiation Oncology +13

Trial of LVDP regimen (l-asparaginase, etoposide, dexamethasone, and cisplatin, followed by radiotherapy) as first-line treatment for newly diagnosed, stage III/IV extranodal natural killer/T cell lymphoma

Y. Q. Wang, Yong Yang, Hongyu Zhuo et al. · Medical Oncology · 2015 · 17 citations

Medicine, Oncology, Pharmacotherapy +11

Endostar, a Modified Endostatin Induces Vascular Normalization to Improve Chemotherapy Efficacy Through Suppression of Src Signaling Pathway

Min Yu, Han Yao, Hongyu Zhuo et al. · Cancer Biotherapy and Radiopharmaceuticals · 2018 · 15 citations

Medicine, Oncology, Pharmacology +17

Identification of the miRNA-mRNA regulatory network associated with radiosensitivity in esophageal cancer based on integrative analysis of the TCGA and GEO data

Hongmin Chen, Xiaoxiao Shi, Li Ren et al. · BMC Medical Genomics · 2022 · 10 citations · Full text

Medicine, Bioinformatics, Oncology +17